세계의 당뇨병 치료 기기 시장 보고서(2025년)
Diabetes Treatment Devices Global Market Report 2025
상품코드 : 1810880
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

당뇨병 치료 기기 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 6.1%로 성장할 전망이며, 156억 1,000만 달러로 성장이 예측됩니다. 예측 기간 동안 예측되는 성장은 웨어러블 및 비침습적 모니터링 장비에 대한 수요 증가, 개별화된 당뇨병 관리에 대한 관심, 디지털 건강 플랫폼 및 앱 채택 확대, 원격 당뇨병 관리 솔루션에 대한 요구 증가, 당뇨병 관리 프로그램을 지원하는 정부 이니셔티브 확대 등 여러 요인으로 인한 것입니다. 이 기간에 주목해야 할 주요 동향으로는 지속적인 포도당 모니터링 기술의 발전, 인공지능과 통합된 첨단 인슐린 전달 시스템 개발, 스마트한 웨어러블 당뇨병 장비의 상승, 비침습적 혈당 모니터링 혁신, 장비 조작에 음성 보조자의 통합 등이 있습니다.

비만률 증가는 당뇨병 관리 솔루션에 대한 수요 증가로 당뇨병 치료 기기 시장의 성장을 가속화할 것으로 예측됩니다. 비만은 비만으로 분류되는 체격 지수(BMI)를 가진 개인의 비율에 의해 결정됩니다. 비만의 급증은 주로 칼로리, 당분, 지방분이 풍부한 식생활의 혼란이 원인이며, 신체 활동으로 균형을 잡지 않으면 체중이 너무 늘어납니다. 당뇨병 치료 기기는 혈당를 관리하는 데 도움이 되며, 따라서 건강한 라이프스타일의 선택을 촉진하고 체중 관리를 지원합니다. 예를 들어, 2023년 9월 미국 질병 예방관리센터(CDC)는 2022년 성인 비만률이 35% 이상이 된 것은 22개 주로 2021년 19개 주에서 증가했다고 보고했습니다. 그 결과, 비만율 증가가 당뇨병 치료 기기 시장을 촉진하고 있습니다.

당뇨병 치료 기기 시장의 주요 기업은 혈당 조절을 강화하고 환자의 당뇨병 관리 부담을 줄이기 위해 하이브리드 폐쇄 루프 인슐린 펌프 시스템과 같은 최첨단 솔루션 개발에 주력하고 있습니다. 하이브리드 폐쇄 루프 인슐린 펌프 시스템은 지속적인 글루코오스 모니터(CGM)의 측정값에 따라 인슐린 투여를 자동으로 조정하는 반면, 사용자는 다이어트 시 인슐린 용량을 수동으로 입력해야 하는 고급 장비입니다. 예를 들어, 메드트로닉 PLC는 2022년 3월 7-80세의 1형 당뇨병 관리용 스마트 가드 기술을 탑재한 미니메드 780G 시스템을 발표했습니다. 이 시스템은 기본 인슐린 수준을 자동으로 조정하고 포도당 수준을 개인화된 목표 범위 내에서 유지하기 위해 5분마다 보정 볼러스를 제공하며, 다이어트 볼러스의 결측과 잘못된 탄수화물 추정치도 보정합니다. 이 시스템은 식사 감지 기술, 핑거 스틱이 필요없는 CGM 및 최대 7 일 동안 지속되는 주입 세트를 갖추고 있으며,이 모든 것을 모바일 앱으로 제어할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Diabetes treatment devices are specialized medical tools designed to help individuals manage and treat diabetes by monitoring blood sugar levels, administering insulin, or addressing related health concerns. These devices play a crucial role in helping patients achieve optimal blood glucose control and prevent complications linked to diabetes.

The primary types of diabetes treatment devices include blood glucose monitoring devices, self-monitoring tools, blood glucose meters, testing strips, lancets, continuous glucose monitoring devices, sensors, transmitters, receivers, and other related equipment. Blood glucose monitoring devices are essential for measuring blood sugar levels, assisting individuals in effectively managing their diabetes. These devices are available through various distribution channels, including hospital pharmacies, retail pharmacies, diabetes clinics, institutional sales, and online pharmacies. They cater to a wide range of users, such as hospitals, homecare settings, diagnostic centers, ambulatory surgery centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The diabetes treatment devices market research report is one of a series of new reports from The Business Research Company that provides diabetes treatment devices market statistics, including diabetes treatment devices industry global market size, regional shares, competitors with a diabetes treatment devices market share, detailed diabetes treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes treatment devices industry. The diabetes treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetes treatment devices market size has grown strongly in recent years. It will grow from $11.61 billion in 2024 to $12.34 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to several key factors, including the rising prevalence of diabetes, greater awareness about effective diabetes management, a growing adoption of insulin delivery devices, increased healthcare expenditure in developing countries, and the expanding availability of advanced glucose monitoring systems.

The diabetes treatment devices market size is expected to see strong growth in the next few years. It will grow to $15.61 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth projected for the forecast period can be attributed to several factors, including a rising demand for wearable and non-invasive monitoring devices, an increasing focus on personalized diabetes care, greater adoption of digital health platforms and apps, a growing need for remote diabetes management solutions, and expanding government initiatives supporting diabetes control programs. Key trends to watch during this period include advancements in continuous glucose monitoring technology, the development of advanced insulin delivery systems integrated with artificial intelligence, the rise of smart wearable diabetes devices, innovations in non-invasive blood sugar monitoring, and the integration of voice assistants into device operations.

The rising obesity rates are anticipated to accelerate the growth of the diabetes treatment devices market due to the increasing demand for solutions to manage diabetes. Obesity is determined by the percentage of individuals with a body mass index (BMI) classified as obese. The surge in obesity is mainly driven by poor dietary habits rich in calories, sugars, and fats, leading to excessive weight gain when not counterbalanced with physical activity. Diabetes treatment devices help manage blood sugar levels, which in turn promotes healthier lifestyle choices and assists in weight management. For instance, in September 2023, the Centers for Disease Control and Prevention (CDC) reported that, in 2022, 22 U.S. states had an adult obesity rate of 35% or higher, an increase from 19 states in 2021. As a result, the growing obesity rates are propelling the diabetes treatment devices market.

Leading companies in the diabetes treatment devices market are focusing on developing cutting-edge solutions like hybrid closed-loop insulin pump systems to enhance glycemic control and alleviate the burden of diabetes management for patients. A hybrid closed-loop insulin pump system is an advanced device that adjusts insulin delivery automatically based on readings from continuous glucose monitors (CGMs) while requiring users to manually input mealtime insulin doses. For instance, in March 2022, Medtronic PLC introduced the MiniMed 780G system with SmartGuard technology for managing type 1 diabetes in individuals aged 7 to 80 years. This system automatically adjusts basal insulin levels and provides correction boluses every five minutes to maintain glucose levels within a personalized target range, even compensating for missed meal boluses or incorrect carbohydrate estimates. The system also features Meal Detection technology, a CGM that eliminates the need for fingersticks, and an infusion set that lasts up to seven days, all of which can be controlled via a mobile app.

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition enables Abbott Laboratories to combine continuous glucose monitoring with smart insulin dosing technology, aiming to deliver more personalized, connected, and accessible diabetes care. Bigfoot Biomedical Inc. is a US-based medical technology company that specializes in developing and providing diabetes treatment devices.

Major players in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH.

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes treatment devices market consists of sales of smart insulin pens, artificial pancreas systems, closed-loop systems, and jet injectors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Treatment Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diabetes treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Diabetes Treatment Devices Market Characteristics

3. Diabetes Treatment Devices Market Trends And Strategies

4. Diabetes Treatment Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetes Treatment Devices Growth Analysis And Strategic Analysis Framework

6. Diabetes Treatment Devices Market Segmentation

7. Diabetes Treatment Devices Market Regional And Country Analysis

8. Asia-Pacific Diabetes Treatment Devices Market

9. China Diabetes Treatment Devices Market

10. India Diabetes Treatment Devices Market

11. Japan Diabetes Treatment Devices Market

12. Australia Diabetes Treatment Devices Market

13. Indonesia Diabetes Treatment Devices Market

14. South Korea Diabetes Treatment Devices Market

15. Western Europe Diabetes Treatment Devices Market

16. UK Diabetes Treatment Devices Market

17. Germany Diabetes Treatment Devices Market

18. France Diabetes Treatment Devices Market

19. Italy Diabetes Treatment Devices Market

20. Spain Diabetes Treatment Devices Market

21. Eastern Europe Diabetes Treatment Devices Market

22. Russia Diabetes Treatment Devices Market

23. North America Diabetes Treatment Devices Market

24. USA Diabetes Treatment Devices Market

25. Canada Diabetes Treatment Devices Market

26. South America Diabetes Treatment Devices Market

27. Brazil Diabetes Treatment Devices Market

28. Middle East Diabetes Treatment Devices Market

29. Africa Diabetes Treatment Devices Market

30. Diabetes Treatment Devices Market Competitive Landscape And Company Profiles

31. Diabetes Treatment Devices Market Other Major And Innovative Companies

32. Global Diabetes Treatment Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Treatment Devices Market

34. Recent Developments In The Diabetes Treatment Devices Market

35. Diabetes Treatment Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기